VEEV Stock Recent News

Industry focused on automation, connectivity, and reporting for proactive quality management PLEASANTON, Calif. , June 9, 2025 /PRNewswire/ -- The 2025 Veeva MedTech Postmarket Quality Benchmark Report reveals that 88% of the medtech companies surveyed are advancing postmarket quality management within the next three years to improve compliance and drive innovation.

Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.

I rate Veeva Systems as a hold, as the current price is close to my new intrinsic value of $322 per share, limiting the margin of safety. Veeva's Q1 FY2026 results were outstanding, driven by Vault CRM migration, AI integration, Crossix performance, and strong SMB sector recovery. Veeva's innovation pace, deep industry specialization, and expanding AI features reinforce its moat versus Salesforce and IQVIA, supporting long-term growth.

Veeva Systems Inc. (NYSE:VEEV ) Annual William Blair Growth Stock Conference June 4, 2025 2:20 PM ET Company Participants Brian Van Wagener - Chief Financial Officer Conference Call Participants Dylan Tyler Becker - William Blair & Company L.L.C., Research Division Dylan Tyler Becker Thank you, everybody.

Leading oncology research organization adopts Veeva Clinical Platform to enhance study delivery PLEASANTON, Calif. and NASHVILLE, Tenn.

Vault CRM will support Astellas' commercial agility and execution PLEASANTON, Calif. , June 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Astellas has chosen Veeva Vault CRM globally and Veeva China CRM for China.

BURLINGAME, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Today, Accumulus Synergy (“Accumulus”) announced a strategic partnership with Veeva Systems (“Veeva”) focused on enabling connectivity to help the life sciences industry more effectively exchange regulated information with national regulatory authorities (NRAs) around the world. The partnership aims to empower customers with the tools needed to meet today's regulatory interoperability demands while maintaining the flexibility to adapt to the evolving regulatory technology landscape.

Life sciences software company Veeva Systems, Inc. (VEEV), beats revenue goals, eyes more growth.

Veeva Systems Inc. (NYSE:VEEV ) Baird Global Consumer, Technology & Services Conference Call June 3, 2025 10:50 AM ET Company Participants Paul Shawah - Executive Vice President of Strategy & Campaign Manager Conference Call Participants Joseph D. Vruwink - Robert W.

Examine Veeva's (VEEV) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.